7/5/2017Why Big Pharma Is Targeting China's Deadliest Diseases

7/5/2017Shareholders Files Class Action against Sinovac over Bribery-related M...

7/5/2017Biological E Licenses Two of Takeda's Vaccines for India and China

7/5/2017BeiGene Initiates Pivotal Trial of PD-1 Antibody BGB-A317 in China

7/5/2017Celgene Enters Partnership for PD-1 Inhibitor BGB-A317 with and Buys 5...

7/5/2017CFDA Issues Announcement for Package Insert Revision of Systemic Quino...

7/4/2017The Chinese National Compound Library Acknowledges Special Contributio...

7/4/2017CFDA Vice Minister Meets Senior Delegation of GAVI Alliance

7/3/2017Top 20 Domestically-listed Pharma Companies by Capitalization in 2017

7/3/2017SMEI Releases Ranking of Top 100 Chinese Pharmaceutical Companies in 2...

7/3/2017New Report: Chinese Pharmaceutical Retail Market Growth Slows Slightly...

7/3/2017CDE Solicits Feedbacks on TCM Clinical and Pharmaceutic Research Guide...

7/3/2017CDE Solicits Comments on Draft Information Guidelines for Pharmaceutic...

7/2/2017CDE Issues Announcement over Organization of Drug Registration Evaluat...

6/30/2017Cost Containment Goes To A New Level with DRG Trial and Renewed Corrup...

6/30/2017CFDA Announces 135 More Voluntary Drug Registration Application Withdr...

6/30/2017Financial-related Company News in Brief

6/30/2017Sanpower Group Closes Acquisition of Dendreon

6/30/2017BeiGene Presents Preliminary Phase 1 Data on HCC Drug Candidate BGB-A3...

6/30/2017New Chinese Study Advances DNA Vaccine Against Dengue Virus

6/29/2017AstraZeneca, Chi-Med Launch Savolitinib Phase III Trial

6/29/2017Recent Executive Moves

6/29/2017NDRC and MOFCOM Jointly Issue the 2017 Edition of Foreign Investment G...

6/29/2017Vivace Therapeutics Raises $40M in Series A & B Financings

6/29/2017China Issues New Policy to Reform and Improve Supply Security Mechanis...

6/29/2017How Do You Solve a Problem Like China's Public Health Care?

6/29/2017Zai Lab Secures Another $30M in Series C Financing

6/29/2017Sinovac to Go Private after Deal with Chinese Consortium

6/29/2017Eisai Temporarily Withdraws NDA for Anticancer Halaven in China

6/28/2017WSJ: Novo Nordisk Wagers Sales Growth Will Offset Price Cuts In China

Page:303/720 Total number of articles:21589: [First][<<] [301] [302] [303] [304] [305] [>>] [End]